GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL
- Country
- Spain
- Type
- Beneficiary
- Website
- www.gsk.es/html/investigacion/espana.html
- Grants received
- 15
Funding record
- 15 grants on record
- €5,965,943.32 awarded in total
- 2011–2024 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
11 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
- BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
- FORSCHUNGSZENTRUM BORSTEL LEIBNIZ LUNGENZENTRUM
- GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION
- Department of Health
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Calls from this organisation
No published calls from this organisation.
Grants received
- New AntiVirals for Infections with Pandemic Potential
- Novel immunotherapies for tuberculosis and other mycobacterial diseases
- EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS
- NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW
- Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments.
- Development of lipid nanoparticles based on solid matrix for Benznidazole oral delivery targeting to the lymphatic system to treat Chagas disease
- Improving the guidelines for Informed Consent, including vulnerable populations, under a gender perspective
- AnTBiotic – progressing TB drug candidates to clinical proof of concept
- Nanotherapeutics for antibiotic resistant emerging bacterial pathogens
- Hit to lead optimisation of novel anti-TB scaffolds through an academic-industrial partnership
- Medicinal Chemistry Open Innovation Doctorates
- A systematic analysis of parasite metabolism - from metabolism to intervention
- Training Network on Zebrafish Infection Models for Pharmaceutical Screens
- European Research Training in the Ubiquitin Proteasome System
- Open Collaborative Model for Tuberculosis Lead Optimisation
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.